FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores

Oct.08.2025
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.

Key points:

 

Action Background: The Director of the FDA, Marty Makary, has announced the launch of a nationwide retailer compliance initiative.

 

Market situation: According to the FDA's estimate, approximately 54% of e-cigarette products on the U.S. market are illegal, with some specifically designed for teenagers, containing flavors such as fruit and candy, and even featuring built-in Bluetooth speakers or gaming capabilities.

 

Health Risk Alert: Industrial chemicals detected in illegal e-cigarettes. These substances are commonly used in the manufacturing of textiles, plastics, and insecticides, and prolonged inhalation may pose serious risks to human health.

 

Key regulatory measures: The FDA will send guidance materials to over 300,000 retail establishments across the United States.

  1. The guidance includes a list of 39 approved e-cigarette products and 20 nicotine pouch products; 
  2. an introduction to the FDA's new "Tobacco Product Search Database" covering over 17,000 legal products; 
  3. retail education materials such as posted reminders that customers must be 21 years old or older to purchase tobacco products.

 

2Firsts, October 8, 2025 - According to the official website of the US Food and Drug Administration (FDA), in an effort to crack down on illegal e-cigarette products and protect the health of young people, FDA Director Marty Makary issued a statement on September 30, officially launching a new initiative aimed at retailers, calling on retail channels including e-cigarette stores, convenience stores, and gas stations to voluntarily cease the sale of illegal e-cigarette products.

 

This initiative aims to enhance retailers' awareness of the legal range of products for sale. The FDA stated that many retailers in communities are still selling illegal e-cigarettes specifically targeted at teenagers with fruit or candy flavors, and even products with built-in video games or Bluetooth speakers. These products are largely unauthorized by the FDA and primarily come from illegal imports from China.

 

According to the FDA's estimate, approximately 54% of e-cigarette products sold in the United States are illegal.

 

These illegal products often contain harmful substances such as formaldehyde, lead, and acetaldehyde, which are commonly used in industrial textiles or insecticides. Prolonged use of these ingredients can pose serious health risks to the human body.

 

In order to help retailers clarify the boundaries between legal and illegal products, the FDA will be sending guidance materials to over 300,000 retail outlets nationwide. The contents include:

 

  • Currently, there are 39 e-cigarette products and 20 nicotine pouch products approved for sale in the US market. This list includes a QR code link to the FDA website for real-time updates. 
  • The FDA has recently launched a Tobacco Product Database, which covers over 17,000 legally marketed tobacco products, including cigarettes, cigars, hookah, and e-cigarettes. 
  • The latest educational materials for retailers, such as calendar-style reminders, emphasize that tobacco products can only be sold to customers aged 21 and above, and photo identification must be checked for customers under the age of 30.

 

Commissioner Makari emphasized:

 

We know that most businesses have a willingness to comply with the law. The goal of this new initiative is to eliminate information blind spots and leave retailers no excuse to sell illegal products.

 

He expressed a particular hope to curb the circulation and sale of illegal e-cigarette products through this action, as these products are currently widely used among young people.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia Brings in Deloitte to Support Illicit Tobacco and Vape Enforcement Across Data, Processes and Project Delivery
Australia’s Department of Home Affairs has hired Deloitte to provide data analytics, business-process, communications and project-delivery support to the Office of the Illicit Tobacco and E-Cigarette Commissioner. The government says Deloitte personnel do not provide policy advice to the Commissioner or the Australian government, with policy development and decision-making remaining with public officials. The arrangement has nevertheless drawn scrutiny because Deloitte has previously provided professional services to several tobacco and vaping companies.
Sep.03
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Product | PMI Launches TEREA Black Mint Pearl in Japan, Adding First Capsule Variant to Black Range With Nationwide Rollout From October 19
Philip Morris Japan (PMJ) launched TEREA Black Mint Pearl on October 15, 2026, introducing the first capsule-equipped heated tobacco stick in the TEREA Black range for IQOS ILUMA devices. The product combines a strong menthol profile with a crushable mint capsule and is priced at ¥640 per 20-stick pack, including tax. Sales began at four IQOS stores and selected retail partners on October 15, with distribution expanding to convenience stores and other tobacco retailers nationwide from October 19. The launch brings Japan's TEREA portfolio to 28 variants, including 21 menthol-related products, or 75% of the range.
product
Oct.16 by 2Firsts Perspectives
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06